Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

Posted on Categories: Investor Relations

Vancouver, BC, April 11, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent and expect to exercise in short order, begins their new cultivation cycle, having received their license to cultivate under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), they are firmly committed to patient safety and the quality of their cannabis.

Read more “Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis”

Invictus MD’s Chairman Provides March in Review

Posted on Categories: Investor Relations

VANCOUVER, BC, April 5, 2017 – INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s Cannabis Company, is pleased to provide a month in review.

March was a transformational time for Invictus MD as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of 50,000 kilograms of high quality cannabis production by 2020.

Read more “Invictus MD’s Chairman Provides March in Review”